MK2-IN-4

• Description :

  MK2-IN-4 is a MAPKAPK2 (MK2) inhibitor with an IC50 value of 45 nM. MK2-IN-4 can be used in the research of cancer, inflammation, immunology[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H315-H319-H335

• Target :

  MAPKAPK2 (MK2)

• Type :

  Reference compound

• Related Pathways :

  MAPK/ERK Pathway

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Cancer; Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/mk2-in-4.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C1NCC2(CC2)C3=C1C4=C(C5=CC(C6=CC(OCCN7C)=C7C=C6)=NC=C5CC4)N3

• Molecular Formula :

  C25H24N4O2

• Molecular Weight :

  412.48

• Precautions :

  P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362-P403+P233-P405-P501

• References & Citations :

  [1]Schlapbach, et al. Heterocyclic compounds useful as MK2 inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. Patent WO2009010488.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1105658-32-9]